thought this might be of some interest
Thalomid Designated Orphan Drug For Crohn's Disease
WASHINGTON, Apr 16 (Reuters) - Celgene Corp. said on Thursday it
had received orphan drug designation to develop its thalidomide
drug for use against Crohn's disease. The drug, which is being
used experimentally against a range of diseases from leprosy to
cancer, is already being tested against Crohn's disease. Getting
orphan drug designation from the US Food and Drug Administration
gives the company exclusive marketing rights in the United States
for 7 years if it is approved for this use.
God Bless All,
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
